La medicina del futuro è bio e “su misura”
La medicina del futuro è bio e “su misura”....
Anemocyte is a BMO, a lead innovator in the field of Advanced Therapies. A dynamic reality, driving force behind projects aiming to truly improve the quality of our lives. A solid organization, thanks to its strong scientific, technical, regulatory expertise, moved by a deep passion for life, today Anemocyte is the place where the Therapies of tomorrow are born.
Anemocyte does not stand alone in its pursuit, as it is part of the Nine Trees Group. Over sixty years of experience, serving the pharmaceutical industry worldwide. Nine Trees Group is an international reality able to combine with passion transversal competences in chemistry and biology, in accordance with the highest international quality standards.
The naming of Anemocyte is the result of the combination of the words “ánemos” and “cyte”. From this union, the Infinite Alpha is created, a symbol that incorporates the values of the company.
Want to know more? Watch the video
Anemocyte dedicates its knowledge and its talents to anticipate and transform this potential into tangible solutions. Anemocyte is at the heart of change, where a challenge becomes a result, and a limit becomes an opportunity. What drives our talents is the love for innovation, the commitment and dedication to constantly improve the quality of the patients’ lives. Our talents are here to restore life, creating a new future.
A future where medicine will be closer to the people and of the people. A future where each individual’s participation can make a crucial and vital difference. Anemocyte aims to become the link between the scientific community and our society, a place where science and soul meet.
At the center of evolution, there are people who believe that change is possible. Here at Anemocyte, we support, value and inspire those with a vision of a different world. A world where science can give life new opportunities. Those who made our mission and vision theirs, find in Anemocyte the perfect environment to develop their abilities. When we find a new talent, we discover potential growth for our company project. Personal skills and the ability to dream go hand in hand with professional and business growth. What we make, is possible only thanks to our talents.
DO YOU THINK YOU HAVE WHAT IT TAKES TO BE PART OF ANEMOCYTE?
Check for our open positions
or
Apply to the Anemocyte Continuous Recruitment Process: we are always looking for interesting candidates with talented souls!
Become an ANEMOCYTER!
Manufacturing of autologous and allogeneic products.
Grade: GMP or High Quality
Plasmid DNA for vaccination or viral vector production.
Grade: GMP or High Quality
Process Development and implementation for viral vector and gene modified cells in our I&D unit.
Grade: High Quality
Anemocyte is the leading Italian producer of gene therapy plasmids and is one of the first of its kind in Europe. Having recently built a brand new Plasmid Manufacturing Unit – which is dedicated to producing plasmids for viral vectors – Anemocyte is equipped with state-of-the-art laboratories and facilities, having tripled its production output since 2018.
Implementation of GMP spaces dedicated to Viral Vectors and Gene Modified cells production for clinical applications.
Grade: GMP or High Quality
Custom GMP spaces to address up to commercial needs.
Scale: up to Commercial.
La medicina del futuro è bio e “su misura”....
Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Phacilitate Leaders World...
In this press release page you can find a selection of the main articles about Anemocyte
published by newspapers and magazines, both online and on paper.
Let’s make real change happen together.
Anemocyte S.r.l.
Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 | 21040 Gerenzano (VA) Italy
Ph: +39 02 96474804 | Fax: +39 02 96474800
VAT number: 12914940155
Share capital € 530.000,00 fully paid
R.E.A. 276961